Oil Prices Slide as Indian Stock Benchmarks Hit 7-Month Winning Streak

Indian equity markets have achieved a significant milestone, recording their longest weekly winning streak in seven months. Driven by a cooling crude oil market and supportive central bank signals, both the Nifty 50 and BSE Sensex showcased resilience despite late-session profit-taking.

Crude Oil Relief Drives Market Sentiment

A primary catalyst for the recent market rally has been the significant decline in global energy prices. Brent crude fell 1.4% to $72.7 per barrel as geopolitical tensions eased following a U.S.-Iran peace deal, leading to increased tanker movement through the Strait of Hormuz.

For India, the world’s third-largest oil importer, this price correction is a major tailwind. Lower oil prices help mitigate inflation concerns and reduce the fiscal pressure on the economy. The impact was clearly visible in the aviation sector, with Interglobe Aviation climbing 8.5% as investors anticipated lower fuel costs.

Monetary Stability and Foreign Inflows

Sentiment was further bolstered by recent policy moves aimed at stabilizing the rupee and attracting foreign capital. The Reserve Bank of India (RBI) has taken proactive steps, including allowing loans against foreign-currency deposits, which has boosted heavyweight financial sectors. Specifically, banks rose 0.9% and private lenders gained 1.5% over the week.

Additionally, RBI Governor Sanjay Malhotra’s recent comments ruling out near-term interest rate hikes have provided much-needed clarity. The prospect of stable borrowing costs is expected to support corporate earnings, consumer spending, and overall market valuations. Furthermore, the government's decision to remove bond taxes for foreign investors is expected to facilitate smoother capital inflows.

Sectoral Divergence: Pharma Gains vs. Metal Losses

The weekly performance showed a distinct divergence across different sectors. The Pharma index emerged as a standout performer, gaining 2.1% this week. This surge was driven by reports of the U.S. FDA engaging with Indian drugmakers regarding a critical cancer drug, as well as investor rotation into sectors less exposed to El Niño risks and crude oil volatility.

In contrast, the metals sector faced significant headwinds, logging a weekly loss of 4.4%. This decline tracked weaker global metal prices, fueled by rising expectations of U.S. interest rate hikes in 2026. While the Nifty 50 and Sensex ended the week up 0.2% and 0.4% respectively, mid-caps faced some pressure, falling 1.2%.

Key Takeaways

• Energy Tailwinds: Falling Brent crude prices (down to $72.7/barrel) have eased inflation fears and boosted sectors like aviation.
• Policy Support: RBI's stance against immediate rate hikes and new measures to mobilize foreign-currency deposits are driving institutional confidence.
• Sectoral Shifts: Investors are pivoting toward defensive sectors like Pharma while pulling back from cyclical sectors like Metals due to global rate uncertainties.